D-0695-2026 Class II Ongoing

Recalled by Blaine Labs Inc — Santa Fe Springs, CA

FDA drug recall D-0695-2026 was initiated by Blaine Labs Inc on Apr 8, 2026 and is designated Class II. Reason for recall: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry The recall status is ongoing. Affected quantity: 22,143 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Apr 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,143 bottles

Product description

TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, NDC 63347-601-01.

Reason for recall

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Distribution pattern

Nationwide in the USA

Code information

Lots BL3431R, Exp Date 10/13/26 & BL3528, Exp Date 08/30/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0695-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0695-2026. Report a data issue: hello@regdatalab.com.